Chapter 4: Stoelting Inhaled Anesthetics Flashcards

1
Q

What were the characteristics of inhaled anesthetics before the 1950s?

A
  • Before 1950, except for nitrous oxide, inhaled anesthetics were either flammable or potentially toxic to the liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What was the significance of introducing fluroxene?

A
  • Introduced in 1951
  • Fluroxene was the first halogenated hydrocarbon anesthetic
  • Developed to decrease flammability
  • It was withdrawn due to potential flammability and organ toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When was halothane synthesized, and what was a concern associated with it?

A
  • Synthesized in 1951
  • Used clinically in 1956
  • Had a tendency to enhance the arrhythmogenic effects of epinephrine.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the key features and drawbacks of methoxyflurane?

A
  • Introduced in 1960
  • Methoxyflurane didn’t enhance epinephrine’s arrhythmogenic effects
  • Caused hepatic toxicity, and nephrotoxicity due to high fluoride levels
  • Prolonged induction, and slow recovery
  • It still sees limited use in Australia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the characteristics of enflurane?

A
  • Introduced in 1973
  • Enflurane doesn’t enhance epinephrine’s arrhythmogenic effects or cause hepatotoxicity
  • It can lead to inorganic fluoride metabolism
  • Lower the seizure threshold.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why was isoflurane introduced, and what are its benefits?

A
  • Introduced in 1981 as a structural isomer of enflurane
  • Isoflurane is resistant to metabolism
  • Reduce the likelihood of organ toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What was the focus in the development of inhaled anesthetics after isoflurane?

A
  • Post-isoflurane, the focus was on creating more pharmacologically “perfect” anesthetics.
  • This led to the development of nonflammable, poorly lipid-soluble, and metabolism-resistant anesthetics by excluding all halogens except fluorine.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When were desflurane and sevoflurane introduced, and what are their characteristics?

A
  • Desflurane 1992
  • Sevoflurane 1994
  • Both totally fluorinated ethers
  • Have low solubility in blood
  • Enables rapid anesthesia induction
  • Precise control during maintenance
  • Prompt recovery.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How did market forces influence the development of desflurane and sevoflurane?

A
  • Acceptance of desflurane and sevoflurane were driven more by market forces like ambulatory surgery and the desire for rapid awakening than by significant pharmacologic improvements over isoflurane.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What challenges arise with the use of desflurane and sevoflurane?

A
  • Airway irritation
  • Sympathetic nervous system stimulation
  • Carbon monoxide production (desflurane)
  • Compound A production (sevoflurane)
  • Dealing with increased manufacturing and administration costs.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What factors influence the cost of new inhaled anesthetics?

A

The cost is influenced by the price per milliliter of liquid, anesthetic characteristics like:

  • Vapor pressure
  • Potency
  • Solubility
  • Fresh gas flow rate used for delivery.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do low fresh gas flow rates affect the cost of inhaled anesthetics?

A
  • Decreases costs.
  • Less soluble anesthetics, like desflurane and sevoflurane, are suited for low flow rates due to better control of delivered concentration and less depletion from inspired gases.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does the potency of desflurane compare to isoflurane, and what does this mean for their delivery?

A
  • Desflurane is one-fifth as potent as isoflurane
  • Only slightly more than threefold the amount of isoflurane is needed to sustain the minimal alveolar concentration (MAC).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Compare the MAC of sevoflurane to isoflurane and its implications on usage.

A
  • The MAC of sevoflurane is 74% greater than isoflurane
  • Only 30% more sevoflurane is needed to sustain MAC.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Physical and chemical properties of the inhaled anesthetic- table

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the commonly administered inhaled anesthetics as of the current clinical practice?

A
  • Nitrous oxide
  • Isoflurane
  • Desflurane
  • Sevoflurane

Halothane and enflurane are used infrequently but are important for comparative pharmacology studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How are volatile liquid anesthetics like diethyl ether and chloroform administered?

A
  • Are administered as vapors after vaporization in devices known as vaporizers.
  • Diethyl ether and chloroform are now mostly used in veterinary medicine.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the characteristics and clinical uses of nitrous oxide?

A
  • Is a low-potency
  • Poorly blood-soluble gas
  • Analgesic and sedative effects
  • Most commonly used with opioids or other volatile anesthetics for general anesthesia.
  • It supports combustion
  • Causes minimal muscle relaxation
  • Can increase the risk of postoperative nausea and vomiting.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the concerns and clinical trial findings regarding nitrous oxide?

A
  • Concerns with nitrous oxide include its effect on gas-containing spaces
  • Vitamin B12 inactivation
  • increased postoperative nausea and vomiting.
  • The IMPACT trial highlighted that the risk of nausea and vomiting with nitrous oxide needs to be weighed against its alternatives, like volatile anesthetics or propofol.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the key characteristics of halothane?

A
  • Halogenated alkane derivative
  • Exist as a clear, nonflammable liquid at room temperature
  • Sweet, bland odor
  • It has intermediate solubility in blood
  • High potency
  • Allows for intermediate onset and recovery from anesthesia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Why was halothane developed, and what are its chemical properties?

A
  • Halothane was developed for its intermediate blood solubility, anesthetic potency, and molecular stability.
  • Its structure includes carbon-fluorine bonds (decreasing flammability), trifluorocarbon (contributing to stability), and carbon-chlorine/bromine bonds plus a hydrogen atom (ensuring potency).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the stability concerns with Halothane, and how is it stored?

A
  • Halothane can decompose into harmful compounds.
  • It is stored in amber-colored bottles with thymol added as a preservative.
  • Residual thymol in vaporizers after halothane vaporization can malfunction vaporizer mechanisms.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the general characteristics of enflurane?

A
  • A Halogenated methyl ethyl ether
  • Is a clear, nonflammable volatile liquid at room temperature with a pungent, ethereal odor.
  • It has intermediate solubility in blood and high potency,
  • Allowing for intermediate onset and recovery from anesthesia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the notable effects of enflurane and its typical usage?

A
  • Lowers the seizure threshold
  • Metabolized in the liver
  • Produce nephrotoxic inorganic fluoride ions.
  • Primarily used in procedures where a low seizure threshold is desired, like electroconvulsive therapy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Is enflurane commonly used in the United States currently?

A

Enflurane is no longer in common use in the United States.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the general characteristics of isoflurane?

A
  • Is a halogenated methyl ethyl ether.
  • existing as a clear, nonflammable liquid at room temperature
  • with a pungent, ethereal odor
  • It has intermediate solubility in blood and high potency, facilitating intermediate onset and recovery from anesthesia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What distinguishes isoflurane in terms of physical stability?

A
  • Extremely stable
  • showing no detectable deterioration over 5 years of storage, even when exposed to carbon dioxide absorbents or sunlight.
  • Its stability negates the need for preservatives like thymol in its commercial form.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What distinguishes desflurane’s chemical structure from isoflurane?

A
  • Desflurane, a fluorinated methyl ethyl ether
  • Has a fluorine atom instead of a chlorine atom on its alpha-ethyl component.
  • This fluorination increases vapor pressure
  • Enhances molecular stability
  • Decreases potency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

How does the vapor pressure of desflurane affect its use, and what technology addresses this?

A
  • Its high vapor pressure is three times that of isoflurane
  • Would cause it to boil at normal operating room temperatures.
  • Special heated and pressurized vaporizers that require electrical power are used to regulate its concentration.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

How is Desflurane metabolized, and what is its potency compared to isoflurane?

A
  • Desflurane is minimally metabolized, with serum and urinary concentrations of trifluoroacetate
  • Significantly lower than those from isoflurane metabolism.
  • Its potency, as indicated by MAC, is about fivefold less than isoflurane.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are the clinical considerations and side effects of using Desflurane?

A
  • Desflurane’s pungency makes inhalation induction unpleasant
  • Cause airway irritation
  • Increasing the risk of salivation, breath holding, coughing, or laryngospasm
  • It also produces the highest carbon monoxide concentrations when degraded by strong bases in desiccated carbon dioxide absorbents.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Why is intraoperative detection of carbon monoxide challenging?

A
  • Pulse oximetry can’t differentiate between carboxyhemoglobin and oxyhemoglobin,
  • Making it difficult to detect carbon monoxide exposure intraoperatively.
  • Low pulse oximetry readings despite adequate arterial oxygen may suggest carbon monoxide exposure.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What are indirect indicators of carbon monoxide formation during anesthesia?

A
  • Decreased pulse oximeter readings
  • Erroneous gas analyzer readings (indicating mixed gases or enflurane when desflurane is used)
  • Can be early warnings of carbon monoxide formation attributed to trifluoromethane production.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

How can carbon monoxide exposure be confirmed intraoperatively?

A
  • Carboxyhemoglobin can be measured acutely with CO-oximetry
  • A technology that is routinely available, to confirm carbon monoxide exposure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What delayed effects can occur due to carbon monoxide poisoning?

A

Delayed neurophysiologic sequelae such as:

  • Cognitive defects
  • Personality changes
  • Gait disturbances
  • May occur 3 to 21 days after anesthesia due to carbon monoxide poisoning.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What are the solubility characteristics and potency of desflurane, and how do they impact its use?

A
  • Desflurane has a blood:gas partition coefficient of 0.42
  • MAC of 6.6%, allowing for rapid achievement of the necessary alveolar partial pressure for anesthesia
  • Prompt awakening upon discontinuation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What are the key characteristics of sevoflurane?

A
  • Sevoflurane, a fluorinated methyl isopropyl ether
  • Has vapor pressure similar to halothane and isoflurane
  • Allowing use with conventional vaporizers.
  • Its solubility ensures quick induction and recovery.
  • It is nonpungent, minimally odorous, and causes less airway irritation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

How does recovery from sevoflurane anesthesia compare to isoflurane?

A
  • Recovery from sevoflurane is 3 to 4 minutes faster than isoflurane
  • Especially noticeable in surgeries longer than 3 hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What are the metabolism characteristics and safety profile of sevoflurane?

A
  • Sevoflurane undergoes more metabolism than desflurane (3% to 5% biodegradation),
  • Produce inorganic fluoride and hexafluoroisopropanol.
  • It doesn’t form reactive acyl halide intermediates or stimulate antitrifluoroacetylated protein antibodies, reducing hepatotoxicity risk.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Is sevoflurane likely to form carbon monoxide?

A
  • Is least likely to form carbon monoxide when exposed to carbon dioxide absorbents.
  • However, it breaks down to form toxic compounds in animals, primarily compound A
  • Although levels in humans are below speculated toxic levels even at low gas flows.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What are the key characteristics and potency of Xenon as an inhaled anesthetic?

A
  • Xenon is an inert gas
  • MAC of 63% to 71%
  • More potent than nitrous oxide.
  • It is nonexplosive, odorless, chemically inert, environmentally friendly
  • Has a blood:gas partition coefficient of 0.115.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What are the cost considerations and potential use of xenon in anesthesia practice?

A
  • Xenon’s high cost limits its use, though this could be offset by low fresh gas flow rates and xenon-recycling systems.
  • Its acceptance depends on demonstrating special properties or significantly lower morbidity
  • Mortality during anesthesia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

How does xenon affect gas exchange conditions?

A
  • Xenon can favor air bubble expansion, which may exacerbate neurologic injury from venous air embolism.
  • It has a minimal effect on bowel expansion compared to nitrous oxide.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

How does the emergence of xenon anesthesia compare to other anesthetics?

A
  • Is 2 to 3 times faster than from equal-MAC nitrous oxide plus isoflurane or sevoflurane.
  • Xenon is a potent hypnotic and analgesic without causing hemodynamic depression.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

What makes xenon’s neuroprotective effects unique among NMDA antagonists?

A
  • Offers neuroprotection without psychotomimetic behavioral changes
  • It does not stimulate dopamine release from the nucleus accumbens, unlike ketamine or nitrous oxide.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Identify the below chemical structure

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Identify the chemical structures below

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Identify the inhaled gases on the graph below

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

What does the FA/FI ratio signify in the induction of anesthesia with inhaled anesthetics?

A
  • Indicates the ratio of end-tidal anesthetic concentration (FA) to inspired anesthetic concentration (FI)
  • Describes the uptake of inhaled anesthetics during induction.
  • It reflects how quickly the anesthetic reaches equilibrium in the lungs.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

How does the solubility of anesthetics affect the FA/FI ratio?

A
  • Anesthetics with lower blood:gas partition coefficients have a more rapid increase in their FA/FI ratio compared to more soluble anesthetics,
  • Indicates faster pulmonary uptake and equilibrium.

Lower blood:gas partition coefficients: nitrous oxide, desflurane, and sevoflurane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

What does a decrease in the rate of change in the FA/FI ratio after 5 to 15 minutes indicate?

A
  • Suggests decreased tissue uptake as vessel-rich group tissues become saturated with the anesthetic.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

What are the four key aspects of inhaled anesthetic pharmacokinetics?

A
  1. Absorption from alveoli to blood
  2. Distribution in the body
  3. Metabolism
  4. Elimination (mainly via lungs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

How does aging affect the pharmacokinetics of volatile anesthetics?

A
  • Aging leads to changes in body composition (less lean mass, more fat)
  • Affects the volume of distribution
  • It may also impair pulmonary gas exchange
  • Reduce cardiac output
  • Alter tissue perfusion and anesthetic distribution.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

How are inhaled anesthetics propelled to their action sites in the CNS?

A
  • A series of partial pressure gradients, starting at the anesthetic machine, move the anesthetic across alveoli, capillaries, and cell membranes to the CNS.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

What is the principal objective of inhalation anesthesia?

A
  • The main goal is to achieve a constant and optimal brain partial pressure of the inhaled anesthetic, correlating with PA (alveolar partial pressure) and PBRAIN (brain partial pressure).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Why is the alveolar partial pressure (PA) of inhaled anesthetics a crucial index?

A
  • Indicates the depth of anesthesia, recovery from anesthesia
  • Anesthetic equal potency (MAC)
  • It mirrors PBRAIN at a steady state
  • allows for control of anesthetic doses to the brain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

What is the difference between equilibration and equality of concentrations in biophases?

A
  • Equilibration means equal partial pressures in two phases, not equal concentrations.
  • This concept is key in controlling doses of volatile anesthetics.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

What factors determine the alveolar partial pressure (PA) of inhaled anesthetics?

A

The balance of input (delivery) into alveoli and uptake (loss) from alveoli into arterial blood.

Input depends on:

  • The inhaled partial pressure (PI)
  • Alveolar ventilation
  • Characteristics of the anesthetic breathing system.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

What influences the input of anesthetics into alveoli?

A

Anesthetic input into alveoli depends on:

  • The inhaled partial pressure (PI) of the anesthetic
  • The rate of alveolar ventilation
  • The design of the anesthetic delivery system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

What factors affect the uptake of inhaled anesthetics from alveoli into pulmonary capillary blood?

A
  • The solubility of the anesthetic in body tissues
  • Cardiac output
  • The alveolar-to-venous partial pressure differences (A-vD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Why is a high inhaled partial pressure (PI) important during initial anesthetic administration?

A
  • To offset anesthetic uptake accelerating anesthesia induction.
  • This quickens the rate of rise in the PA and PBRAIN.
  • As uptake decreases over time, PI should be reduced to maintain a constant and optimal PBRAIN.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

What is the concentration effect in the context of inhaled anesthetics?

A
  • States that a higher PI leads to a more rapid increase in PA
  • As the higher concentration offsets uptake, speeding up the PA’s rise.
  • It results from a concentrating effect and augmentation of tracheal inflow.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

What mechanisms contribute to the concentration effect?

A
  • Concentrating the anesthetic in a smaller lung volume due to gas uptake
  • while increased tracheal inflow fills the space produced by gas uptake
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

What is the second gas effect, and how does it work?

A
  • Occurs when the high-volume uptake of a primary gas (first gas) accelerates the PA rise of a secondary gas (second gas)
  • It’s due to increased tracheal inflow and concentration of the second gas in a reduced lung volume from the high-volume uptake of the first gas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

What is a common misconception about gas volume compensation in the lungs?

A
  • It’s misleading to suggest that extra gas is routinely drawn into the lungs to compensate for lost lung volume.
  • Compensatory changes may include decreased expired ventilation or a decrease in lung volume, not just increased inspired ventilation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

How does increased alveolar ventilation affect the induction of anesthesia?

A
  • Accelerates the input of anesthetics, raising the PA more rapidly towards the PI.
  • speeds up anesthesia induction.
  • Hyperventilation can decrease cerebral blood flow (CBF), which might offset the increased anesthetic delivery to the brain.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

What is the effect of decreased alveolar ventilation on anesthesia induction?

A
  • Reduces anesthetic input
  • Slows the establishment of the necessary PA and PBRAIN for anesthesia induction.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

How does the alveolar ventilation to functional residual capacity (FRC) ratio affect anesthesia induction?

A
  • A higher alveolar ventilation to FRC ratio leads to a faster rate of increase in PA.
  • Neonates have a higher ratio (about 5:1) compared to adults (1.5:1)
  • Results in quicker anesthesia induction in neonates due to their higher metabolic rate.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

How do inhaled anesthetics affect alveolar ventilation?

A
  • Have a dose-dependent depressant effect on alveolar ventilation
  • Creates a negative feedback mechanism
  • Prevents excessive anesthesia depth during spontaneous breathing
  • Decrease anesthetic delivery when ventilation is reduced.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

What happens to the anesthetic distribution when ventilation decreases during spontaneous breathing?

A
  • Anesthetics redistribute from high-concentration tissues (like the brain) to low-concentration tissues (like skeletal muscles).
  • When brain concentration drops below a threshold, ventilation increases, raising anesthetic delivery to the lungs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

What protective mechanism is lost during mechanical ventilation?

A
  • Mechanism against excessive anesthesia depth, which is present during spontaneous breathing
  • This is because mechanical ventilation maintains consistent anesthetic delivery regardless of the brain’s anesthetic concentration.

Mechanism against excessive anesthesia depth, which is present during spontaneous breathing, is lost during mechanical ventilation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

How does the solubility of an anesthetic in the blood affect the impact of alveolar ventilation changes on the PA?

A
  • Changes in alveolar ventilation influence the PA of soluble anesthetics (like halothane, and isoflurane)
  • More than poorly soluble ones (like nitrous oxide, desflurane, sevoflurane).
  • Poorly soluble anesthetics have a rapid PA increase regardless of ventilation changes due to limited uptake.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

What is the difference in uptake between more blood-soluble and poorly soluble anesthetics?

A
  • More blood-soluble anesthetics have greater uptake; thus, increasing alveolar ventilation accelerates the PA’s approach to the PI.
  • Conversely, uptake of poorly soluble anesthetics is limited, so their PA rises rapidly regardless of ventilation changes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

How does changing from spontaneous to mechanical ventilation affect anesthesia depth?

A
  • Increased alveolar ventilation, likely increases the depth of anesthesia (PA) for more blood-soluble anesthetics.
  • Due to faster PA rise towards the PI.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

What characteristics of the anesthetic breathing system influence the PA rate of increase?

A
  • The system’s volume (acting as a buffer).
  • Solubility of anesthetics in the system’s materials.
  • Gas inflow rate from the anesthetic machine.
  • High gas inflow rates can negate the buffering effect of the system’s volume.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

How does the volume of the anesthetic breathing system affect anesthetic PA?

A
  • Slows the achievement of the target PA by acting as a buffer.
  • High gas inflow rates can counteract this buffering effect.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

What is the impact of anesthetic solubility on breathing system components?

A
  • Initially slows the PA’s rate of increase.
  • At the end of anesthetic administration, the reverse gradient causes anesthetic elution, slowing the PA’s rate of decrease.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Which anesthetic gas is the only soluble among others?

A

Methoxyflurane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Which anesthetic gases are immediately soluble?

A
  • Halothane
  • Enflurane
  • Isoflurane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Which anesthetic gases are poorly soluble?

A
  • Nitrous Oxide
  • Desflurane
  • Sevoflurane
  • Xenon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

What is a partition coefficient in the context of inhaled anesthetics?

A
  • Is a distribution ratio that describes how an inhaled anesthetic distributes itself between two phases (like blood and gas) at equilibrium.
  • It indicates the concentration relationship of the anesthetic in these phases when their partial pressures are equal.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

How do you interpret a blood:gas partition coefficient for inhaled anesthetics?

A
  • Blood:gas partition coefficient of 0.5 means the concentration of the anesthetic in the blood is half that in alveolar gases when their partial pressures are equal.
  • It indicates the solubility and distribution of the anesthetic between blood and gas.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

What does a brain:blood partition coefficient indicate?

A
  • A brain:blood partition coefficient of 2 means the concentration of anesthetic in the brain is twice that in the blood when their partial pressures are equal.
  • It shows the relative concentration of anesthetic in the brain versus blood.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

How does temperature affect partition coefficients?

A
  • Partition coefficients are temperature-dependent.
  • The solubility of a gas in a liquid decreases as the temperature of the liquid increases.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

How does the solubility of an anesthetic in blood affect the rate of increase of the PA towards the PI?

A
  • The rate of PA increase towards the PI is inversely related to the anesthetic’s solubility in blood.
  • Highly soluble anesthetics like methoxyflurane require more anesthetic to be dissolved in blood for PA to equilibrate with PI, leading to slower induction.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

What is the overpressure technique in anesthesia, and when is it used?

A
  • The technique involves delivering a higher PI than required for the maintenance of anesthesia to speed up induction.
  • Particularly with highly soluble anesthetics.
  • Sustained high PI can result in overdose.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

How does low blood solubility of anesthetics like nitrous oxide, desflurane, or sevoflurane affect anesthesia induction?

A
  • Low blood solubility means minimal anesthetic needs to be dissolved for equilibration.
  • Results in rapid PA increase.
  • Quicker onset of effects ( anesthesia induction).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

What are the unique effects of nitrous oxide due to its high-volume absorption?

A
  • At concentrations of 60-70%, leads to unique effects when used with volatile anesthetics or in air-containing cavities.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

How do individual variations affect blood:gas partition coefficients?

A

Vary with individual differences in:

  • Water.
  • Lipid Protein content.
  • Hematocrit levels.

For example, lower hematocrit or a recent fatty meal can affect the solubility of volatile anesthetics in blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

How does age affect the solubility of inhaled anesthetics in blood?

A
  • The solubility of certain anesthetics like halothane, enflurane, methoxyflurane, and isoflurane is about 18% less in neonates and the elderly.
  • For less soluble anesthetics like sevoflurane, there’s no significant difference in solubility between neonates and adults.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

What role do tissue:blood partition coefficients play in anesthetic administration?

A
  • Determines the uptake of anesthetics into tissues.
  • The time needed for tissues to equilibrate with the arterial partial pressure of anesthetics (Pa).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

How is the time for equilibration of tissues with Pa estimated?

A
  • Is estimated by calculating a time constant, defined as the amount of inhaled anesthetic that can be dissolved in the tissue divided by tissue blood flow.
  • One time constant represents 63% equilibration.
  • Three time constants equal 95% equilibration.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

How long does it take for the brain to equilibrate with volatile anesthetics?

A
  • Usually requires 5 to 15 minutes, or about three time constants, depending on the anesthetic’s blood solubility.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

What is the estimated equilibration time of fat with isoflurane?

A
  • Is based on its fat:blood partition coefficient
  • Assumed fat blood flow, is estimated to be 25 to 46 hours for three time constants.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

How does fasting before surgery affect anesthetic uptake?

A
  • Fasting leads to the transport of fat to the liver
  • potentially increasing anesthetic uptake by the liver
  • modestly slowing the rate of increase in the alveolar partial pressure (PA) of a volatile anesthetic during induction.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

How are oil:gas partition coefficients related to anesthetic requirements?

A
  • Are directly related to anesthetic requirements.
  • An anesthetic’s MAC (Minimum Alveolar Concentration) can be estimated as 150 divided by the oil:gas partition coefficient.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

How can you calculate the estimated MAC for an anesthetic?

A
  • Divide 150 by the anesthetic’s oil:gas partition coefficient.

150 is a constant representing the average product of oil:gas solubility and MAC for various anesthetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

What would be the calculated MAC for an anesthetic with an oil:gas partition coefficient of 100?

A

For an anesthetic with an oil:gas partition coefficient of 100, the calculated MAC would be 1.5% (150 divided by 100).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

How does nitrous oxide accumulate in closed gas spaces, and what are the consequences?

A

Nitrous oxide has a high blood:gas partition coefficient (0.46) compared to nitrogen (0.014), allowing it to rapidly accumulate in air-filled cavities, increasing volume or pressure, potentially leading to damage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

How does nitrous oxide affect different types of body cavities?

A
  • In compliant cavities (like intestinal gas or pneumothorax), nitrous oxide causes expansion.
  • In noncompliant cavities (like the middle ear or cerebral ventricles), it increases intracavitary pressure.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

What factors influence the impact of nitrous oxide in closed spaces?

A
  • Partial pressure of nitrous oxide.
  • Blood flow to the cavity.
  • The duration of nitrous oxide administration.
  • In high-flow areas, volume increases can be rapid.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

How does nitrous oxide affect middle ear pressure?

A
  • Diffuses into the middle ear faster than nitrogen leaves, potentially increasing ear pressure
  • Especially if the Eustachian tube is blocked
  • Leads to tympanic membrane rupture or serous otitis after anesthesia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

What is the effect of nitrous oxide on intraocular gas bubbles used in eye surgeries?

A
  • Can rapidly increase the volume of intraocular gas bubbles, enough to compress the retinal artery.
  • Potentially cause visual loss, especially critical in the weeks following ocular surgery.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

How does cardiopulmonary bypass affect blood-gas solubility?

A
  • Changes in blood-gas solubility, influenced by the priming solution and temperature.
  • The overall effect of hypothermic bypass and a crystalloid prime on solubility is about 2%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

How does cardiopulmonary bypass affect the equilibration of volatile anesthetics?

A
  • Volatile anesthetics initiated take longer to equilibrate.
  • If the anesthetics are already present when the bypass begins, they may be diluted, potentially reducing anesthesia depth.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

How does cardiac output influence anesthetic uptake and the rate of increase in the PA?

A

Increased cardiac output:

  • rapid uptake of anesthetic from the alveoli.
  • Slowing the increase in PA and anesthesia induction.

Decreased cardiac output:

  • Speeds up PA increase due to less anesthetic uptake.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

Why does increased cardiac output paradoxically lower Pa despite hastening equilibration in tissues?

A
  • While increased cardiac output hastens the equilibration of tissue anesthetic partial pressures with Pa, it actually lowers the Pa than if cardiac output were normal, due to increased anesthetic uptake.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

How do changes in cardiac output affect soluble vs. poorly soluble anesthetics?

A
  • Changes in cardiac output significantly influence the PA rate of increase for soluble anesthetics
  • Have little effect on poorly soluble anesthetics like nitrous oxide, regardless of cardiac output variations.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

How can volatile anesthetics impact cardiac output and what is the feedback response?

A
  • May depress cardiac output, leading to a positive feedback response where decreased output raises PA
  • Deepening anesthesia and further depressing cardiac function.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

How does the distribution of cardiac output affect the PA of an anesthetic?

A
  • Increases in cardiac output may not proportionally increase blood flow to all tissues.
  • Preferential perfusion of vessel-rich tissues can lead to a faster increase in PA than if the increased cardiac output were evenly distributed.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

How does a right-to-left shunt affect the PA and Pa of inhaled anesthetics?

A
  • Dilutes anesthetic partial pressure in blood from ventilated alveoli
  • Decrease Pa
  • Slows anesthesia induction.
  • It creates a gradient where PA underestimates Pa, similar to its effect on PaO2.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

How does the solubility of an anesthetic influence its rate of increase in Pa in the presence of a right-to-left shunt?

A
  • A right-to-left shunt slows the rate of increase of Pa for poorly soluble anesthetics
  • Soluble anesthetics’ uptake offsets the dilutional effects of shunted blood
  • Uptake of poorly soluble anesthetics is minimal.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

How does the impact of a shunt contrast with changes in cardiac output and alveolar ventilation?

A

The impact of solubility in the presence of a right-to-left shunt is opposite to that observed with changes in cardiac output and alveolar ventilation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

What is the effect of left-to-right tissue shunts on anesthetic Pa?

A

Left-to-right shunts (like arteriovenous fistulas) deliver blood with a higher anesthetic partial pressure to the lungs, offsetting the dilutional effects of a right-to-left shunt on Pa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
118
Q

How do right-to-left and left-to-right shunts interact to influence the PA of anesthetics?

A
  • Right-to-left shunt on slowing PA increase is maximal without a left-to-right shunt.
  • Left-to-right shunts can only offset right-to-left shunt effects if both types of shunts are present.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
119
Q

What does the A-vD indicate in the context of inhaled anesthetics?

A
  • The A-vD reflects tissue uptake of inhaled anesthetics.
  • It affects lung uptake by controlling the rate of increase of the mixed venous partial pressure of the anesthetic, influenced by tissue solubility, blood flow, and arterial-to-tissue pressure differences.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
120
Q

How do vessel-rich group tissues affect anesthetic uptake?

A
  • Equilibrate rapidly with arterial anesthetic pressure (Pa) due to high blood flow and low mass.
  • After three time constants, venous blood pressure equilibrates with alveolar pressure (PA), decreasing anesthetic uptake.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
121
Q

What is the role of skeletal muscles and fat in sustained anesthetic uptake?

A
  • Skeletal muscles and fat, comprising a large body mass but receiving less cardiac output
  • Continue to take up anesthetics for an extended period, maintaining the A-vD and continuous uptake from the lungs.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
122
Q

How does equilibration time for vessel-rich group tissues differ in neonates and infants compared to adults?

A
  • Is faster in neonates and infants due to greater cardiac output to these tissues and decreased solubility of anesthetics in their tissues.
  • Skeletal muscle mass is a smaller fraction of body weight in the very young.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
123
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
124
Q

What factors influence the rate of recovery from anesthesia?

A
  1. Rapid washout from the brain
  2. Low solubility in brain tissue
  3. High cardiac output to the brain.

The rate of decrease in the brain’s partial pressure (PBRAIN) as reflected by the alveolar partial pressure (PA).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
125
Q

How do induction and recovery from anesthesia differ?

A
  • Unlike induction, which can be accelerated by the concentration effect, recovery can’t be sped up similarly since you can’t administer less than zero.
  • Tissue concentrations at recovery’s start depend on the anesthetic’s solubility and administration duration.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
126
Q

How does tissue equilibrium with PA affect the recovery rate?

A

Since some tissues (like skeletal muscles and fat) may not equilibrate with PA during maintenance, the PA decrease rate during recovery is faster than its increase rate during induction. These tissues continue taking up anesthetic, aiding PA decrease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
127
Q

How do the solubility of the anesthetic and duration of anesthesia impact recovery?

A
  • Recovery time is prolonged for soluble anesthetics (like halothane, isoflurane) in proportion to anesthesia duration.
  • For poorly soluble anesthetics (like sevoflurane, desflurane), duration has minimal impact on recovery time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
128
Q

How does anesthetic absorption into breathing system components affect recovery?

A
  • Will pass back into the breathing circuit gases at anesthesia’s end slowing the PA decrease rate.
  • Increasing fresh gas flow rates at conclusion can help mitigate rebreathing of exhaled anesthetics.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
129
Q

What is the context-sensitive half-time in relation to inhaled anesthetics?

A
  • Refers to the pharmacokinetics of the elimination of inhaled anesthetics, which depends on the duration of administration and the blood-gas solubility of the anesthetic.
  • It varies for different anesthetics and increases with the duration of anesthesia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
130
Q

How do recovery times differ among desflurane, sevoflurane, and isoflurane?

A
  • Recovery is fastest with desflurane (most insoluble) and
  • Slowest with isoflurane (most soluble).
  • For short procedures (around 30 minutes), there’s little difference in recovery time among these anesthetics.
  • The difference becomes appreciable in longer procedures.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
131
Q

How can sevoflurane be managed to ensure rapid recovery in longer procedures?

A

In longer procedures (3-4 hours), turning off sevoflurane about 30 minutes before the end and replacing it with 70% nitrous oxide can ensure rapid recovery by allowing adequate time for a 90% decrease in sevoflurane concentration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
132
Q

What characterizes the initial phase of anesthetic elimination?

A
  • The initial phase of elimination, primarily driven by alveolar ventilation,
  • Reflected in the 50% decrement time of various anesthetics,
  • which is typically less than 5 minutes and doesn’t increase much with anesthesia duration.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
133
Q

How do 80% and 90% decrement times vary among different anesthetics?

A
  • Desflurane and sevoflurane have 80% decrement times under 8 minutes
  • Enflurane and isoflurane, these times increase after 60 minutes.
  • The 90% decrement time of desflurane increases slightly with longer anesthesia but remains significantly less than for other anesthetics after 6 hours.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
134
Q

What is diffusion hypoxia, and how is it related to nitrous oxide?

A
  • Occurs when nitrous oxide is abruptly discontinued
  • Causes it to rapidly leave the blood and enter the alveoli, diluting the PAO2 (alveolar oxygen partial pressure)
  • Potentially lowering the PaO2 (arterial oxygen partial pressure).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
135
Q

What are the consequences of diffusion hypoxia?

A
  • Can dilute both PAO2 and PACO2 (alveolar carbon dioxide partial pressure).
  • Reduces the stimulus to breathe.
  • Exacerbates the decrease in PaO2.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
136
Q

How is diffusion hypoxia managed at the end of anesthesia?

A
  • Administer oxygen to fill the lungs at the end of anesthesia,
  • It counteract the dilution of PAO2 by nitrous oxide.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
137
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
138
Q

What is the MAC of an inhaled anesthetic?

A
  • Is the concentration of an inhaled anesthetic at 1 atm that prevents movement in response to a painful stimulus in 50% of patients.
  • It’s considered the anesthetic 50% effective dose (ED50) for immobility.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
139
Q

What part of the nervous system is primarily affected by inhaled anesthetics as measured by MAC?

A
  • The MAC primarily reflects the effects of inhaled anesthetics on the spinal cord, with a minor component resulting from cerebral effects.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
140
Q

Why is the MAC concept important in anesthetic pharmacology?

A
  • MAC provides a uniform measure of potency for inhaled anesthetics
  • allows for standardization of dosages
  • comparison of drugs
  • investigation into mechanisms of anesthetic action.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
141
Q

How does pharmacodynamic variability affect MAC among individuals?

A
  • MAC shows a remarkably small pharmacodynamic variability
  • Varying only 10-15% among individuals.
  • This consistency is unique in pharmacology.
142
Q

What are MAC-awake and MAC-memory?

A
  • MAC-awake is the concentration of an anesthetic that prevents consciousness in 50% of patients, typically about half of the MAC.
  • MAC-memory is even lower, associated with amnesia in 50% of patients.
143
Q

Physiologic and Pharmacologic Factors that Increase MAC

A
  • Hyperthermia
  • Excess pheomelanin production (red hair)
  • Drug-induced increases in CNS catecholamines levels (cocaine, methamphetamines, amphetamines)
  • Cyclosporine
  • Hypernatremia
144
Q

Physiologic and Pharmacologic Factors that decrease MAC

A
  • Hypothermia
  • Increasing age
  • Preoperative medication
  • Drug-induced decreases in CNS catecholamine levels
  • Alpha2 Agonist
  • Acute ETOH ingestion
  • Pregnancy
  • Postpartum (returns to normal in 24-72 hr)
  • Lidocaine
  • Neuraxial opioids
  • PaO2 < 38 mmHg
  • MAP < 40 mmHg
  • Cardiopulmonary bypass
145
Q

Physiologic and Pharmacologic Factors that cause NO change in MAC

A
  • Anesthetic metabolism
  • Chronic alcohol abuse
  • Sex
  • Duration of anesthesia
  • PaCo2 15-95 mmHg
  • PaO2 > 38 mmHg
  • BP > 40 mmHg
  • Hyperkalemia or Hypokalemia
  • Thyroid gland dysfunction
146
Q

How uniform are inhalation anesthetic requirements among humans?

A
  • Remarkably uniform in humans
  • Primarily influenced by age and body temperature.
147
Q

How does age affect MAC?

A
  • Increasing age leads to a progressive decrease in MAC,
  • With a reduction of about 6% per decade
  • Consistent across all inhaled anesthetics.
148
Q

How does pregnancy and the early postpartum period affect MAC?

A
  • MAC decreases by nearly 30% during pregnancy and the early postpartum period.
  • Returning to normal within 12 to 72 hours after childbirth.
149
Q

How does MAC relate to awareness in parturients?

A
  • Despite a reduction in MAC during pregnancy, the incidence of postoperative awareness is higher.
  • Especially after cesarean sections.
  • This indicates that the concentration-response in the brain isn’t significantly altered in pregnancy.
150
Q

Is the anesthetic concentration required for brain response altered in pregnancy?

A
  • Is required to induce EEG changes associated with hypnosis
  • Is not changed in pregnancy, indicating that brain response to anesthetic concentrations remains consistent.
151
Q

Does gender influence MAC?

A
  • Gender does not influence MAC
  • Except in women with natural red hair who have increased MAC possibly due to mutations in the melanocortin-1 receptor gene.
152
Q

What is the effect of cardiopulmonary bypass on MAC?

A

The impact of cardiopulmonary bypass on MAC is uncertain, with studies showing either a decrease or no change.

153
Q

How does cyclosporine affect isoflurane MAC?

A
  • Cyclosporine increases Isoflurane MAC
  • Despite prolonging sleeping times in animals.
154
Q

Does MAC vary with the type of stimulus?

A
  • MAC values may vary with different types of stimuli.
  • Tracheal intubation requires the highest MAC to prevent muscle responses, representing a more intense stimulus than surgical skin incision.
155
Q

Are the effects of inhaled anesthetics additive?

A
  • Yes, the effects of inhaled anesthetics are additive.
  • For example, 0.5 MAC nitrous oxide plus 0.5 MAC isoflurane equals the effect of 1 MAC of either anesthetic alone.
156
Q

How do opioids affect anesthetic requirements for volatile anesthetics?

A
  • Opioids synergistically decrease anesthetic requirements.
  • Fentanyl reduces desflurane MAC by 48% to 68%, depending on the dose.
157
Q

Are the interactions between volatile and intravenous anesthetics additive or synergistic?

A
  • Interactions are mostly synergistic, not additive.
  • Different receptor actions or mechanisms typically lead to synergism.
158
Q

How steep are the dose-response curves for inhaled anesthetics?

A
  • Dose-response curves for inhaled anesthetics are steep.
  • A dose of 1 MAC prevents movement in response to a painful stimulus in 50% of patients.
  • 1.3 MAC prevents movement in at least 95% of patients.
159
Q

What is the general understanding of the mechanism of volatile anesthetic action?

A
  • The exact mechanism of volatile anesthetic action remains unclear.
  • Unlike most drugs with known specific molecular binding sites, the mode of action for volatile anesthetics is still a significant mystery.
160
Q

What does the Meyer-Overton theory propose about the action of inhaled anesthetics?

A
  • Suggests that inhaled anesthetics act by disrupting nerve membrane structures or dynamics, with potency correlating with lipid solubility (oil:gas partition coefficient).
  • Anesthetics dissolve in lipid cell membranes, affecting ion channels and synaptic transmission.
161
Q

How might volatile anesthetics distort sodium channels according to the Meyer-Overton theory?

A
  • By dissolving in lipid membranes, altering their shape and function.
  • This theory is supported by the fact that high pressures can partially reverse anesthetic effects by compressing membranes back to their normal state.
162
Q

What evidence challenges the Meyer-Overton theory?

A

The theory’s limitations include:

  • the minimal effect of anesthetics on lipid bilayer fluidity.
  • the fact that not all lipid-soluble drugs are anesthetics.
  • Some lipid-soluble drugs, like certain n-alcohols, are actually convulsants.
163
Q

How have lipid theories been refined in light of new evidence?

A

Refined lipid theories suggest that specialized domains in membranes, particularly those surrounding proteins, are sensitive to anesthetics and crucial to membrane function. Anesthetic effects could be due to binding to proteins or dissolving in lipids.

164
Q

What is the significance of stereoselectivity in the context of inhaled anesthetics?

A
  • Stereoselectivity refers to the different effects of anesthetic isomers on neuronal channels.
  • For instance, isoflurane’s levoisomer is more potent than its dextroisomer in enhancing potassium conductance in neurons and in anesthetic potency.
165
Q

How do isoflurane’s isomers differ in their anesthetic effects?

A
  • The levoisomer of isoflurane is more potent than the dextroisomer,
  • both in enhancing neuronal potassium conductance and in overall anesthetic potency, as shown by differences in MAC in rats.
166
Q

Are there inconsistencies in findings regarding the stereoselectivity of inhaled anesthetics?

A
  • Yes, some studies have not found significant differences in the effects of enantiomers of isoflurane and desflurane on anesthetic effects in animals, suggesting variability in stereoselectivity findings
167
Q

How does the molecular structure of anesthetics relate to their mechanism of action?

A

Receptor specificity in anesthetics is indicated by changes in anesthetic effects when molecular volume is increased, even though lipid solubility also increases. However, molecular shape and size offer limited insight into the anesthetic binding site structure.

168
Q

What are the differences between ionotropic and metabotropic receptors?

A
  • Ionotropic receptors, or ligand-gated ion channels, directly bind neurotransmitters to open ion channels, affecting membrane potential.
  • They are often multi-subunit structures.
  • Metabotropic receptors, typically monomeric, activate G proteins upon neurotransmitter binding, influencing other signaling molecules.
169
Q

What is the composition of ionotropic receptors?

A

Ionotropic receptors like GABAA and nicotinic acetylcholine receptors are made from various subunits that form pleomorphic receptors, adapting to different neurotransmitters and functions.

170
Q

How do metabotropic receptors function?

A

Metabotropic receptors, upon binding with neurotransmitters like acetylcholine, activate G proteins, which then function as second messengers to activate protein kinases or modulate potassium or calcium channels.

171
Q

Do inhaled anesthetics stimulate the release of endogenous opioids?

A

Inhaled anesthetics do not appear to stimulate endogenous opioid release, nor do they suppress ventilatory responses to surgical stimulation at movement-suppressing concentrations.

172
Q

How do small doses of opioids affect MAC?

A

Small doses of opioids decrease MAC, indicating their ability to provide analgesic effects, which are absent in inhaled anesthetics alone.

173
Q

What is the role of glycine receptors in the action of inhaled anesthetics?

A

Glycine receptors, primarily located in the spinal cord, are potentiated by volatile anesthetics and may mediate part of the immobility effect (as defined by MAC) produced by these anesthetics.

174
Q

How do GABAA receptors interact with inhaled anesthetics?

A

While GABAA receptors are potentiated by volatile anesthetics, their enhancement at clinical concentrations has minimal influence on MAC, suggesting they do not majorly mediate the immobility caused by inhaled anesthetics.

175
Q

Do GABAA receptors mediate the effects of injected anesthetics?

A

β3–subunit–containing GABAA receptors mediate hypnosis and part of the immobility produced by injected anesthetics like propofol and etomidate.

176
Q

How do inhaled anesthetics affect excitatory neurotransmission in the CNS?

A

Inhaled anesthetics decrease excitatory neurotransmission, primarily mediated by glutamate, the main excitatory neurotransmitter in the mammalian CNS.

177
Q

What types of glutamate receptors are affected by inhaled anesthetics?

A

Glutamate receptors affected include G protein–coupled receptors and ligand-gated receptors such as NMDA, AMPA, and kainate. NMDA receptors, in particular, may mediate some behavioral effects of inhaled anesthetics.

178
Q

How do volatile anesthetics differ in their efficacy for NMDA receptor blockade?

A

At 1 MAC, volatile anesthetics inhibit NMDA receptors to varying degrees, ranging from 14% (sevoflurane) to 39% (Xenon). Anesthetics with cation-π interactions show greater NMDA blockade.

179
Q

What is the role of two-pore potassium channels in cellular function?

A

Two-pore potassium channels help maintain the cell’s resting potential and respond to internal stimuli, such as changes in pH. They are intrinsic membrane receptor/ion channels.

180
Q

How do volatile anesthetics interact with two-pore potassium channels?

A

Volatile anesthetics potentiate the activity of two-pore potassium channels, particularly TREK and TASK channels, in an agent-specific manner. These channels are sensitive to anesthetics at clinically used concentrations.

181
Q

What is the significance of TASK-3 receptors in anesthesia?

A

TASK-3 receptors, sensitive to anesthetics, play a role in maintaining theta oscillations in the EEG, which are associated with anesthesia and natural deep sleep durations

182
Q

How might TASK channels contribute to anesthetic-induced neuroprotection?

A

TASK channel interaction with anesthetics may contribute to neuroprotective effects during ischemia-reperfusion injury, a potential benefit of anesthetic intervention.

183
Q

What is the significance of the different subtypes of sodium channels in anesthetic action?

A

There are many subtypes of sodium channels, each playing different roles. Some subtypes, particularly those modulating neurotransmitter release, are more sensitive to anesthetics than those mediating axonal conduction.

184
Q

How do anesthetics affect sodium channels involved in neurotransmitter release?

A

Anesthetics interact with specific subtypes of sodium channels at presynaptic junctions, inhibiting the release of neurotransmitters like glutamate.

185
Q

How does lidocaine, a sodium channel blocker, influence MAC?

A

Intravenous administration of lidocaine, which nonspecifically blocks sodium channels, has been shown to decrease MAC, indicating the role of sodium channels in anesthetic potency.

186
Q

What is the role of hyperpolarization-activated cyclic nucleotide–gated channels?

A

These are voltage-gated ion channels crucial in regulating rhythmogenicity in the heart and brain, expressed throughout the body.

187
Q

How does halothane affect hyperpolarization-activated cyclic nucleotide–gated channels?

A

Halothane may influence these channels in motor neurons, potentially contributing to anesthetic immobility.

188
Q

What underlies the immobility produced by inhaled anesthetics, as represented by MAC?

A

MAC represents the ability of inhaled anesthetics to induce immobility primarily through actions on the spinal cord, rather than higher brain centers. This is why immobility during noxious stimulation doesn’t correlate with cortical EEG activity.

189
Q

How do inhaled anesthetics affect the spinal cord to produce immobility?

A

Inhaled anesthetics depress excitatory AMPA and NMDA receptor-mediated currents and potentially act on two-pore potassium channels, contributing to immobility. However, they do not significantly affect inhibitory GABAA or glycine receptors in this context.

190
Q

Do nicotinic acetylcholine receptors play a significant role in anesthetic-induced immobility at the spinal cord level?

A

No, nicotinic acetylcholine receptors do not significantly contribute to anesthetic-induced immobility at the spinal cord level.

191
Q

How do opioids and α2-adrenergic receptor stimulation affect MAC?

A

While opioids and α2-adrenergic receptor stimulation (like clonidine) decrease MAC, they are unlikely to be the mechanisms by which inhaled anesthetics produce immobility. Inhaled anesthetics do not act via opioid receptors.

192
Q

Can immobility induced by inhaled anesthetics be attributed to a single group of receptors?

A

No single receptor group action can fully explain the immobility caused by inhaled anesthetics. It is unlikely that immobility results from concurrent actions on many different receptors.

193
Q

What is the current understanding of how volatile anesthetics cause loss of consciousness?

A

The exact mechanism of anesthesia-induced unconsciousness is not fully understood. It is studied as the loss of righting reflex in animals and loss of response to command in humans, with distinct molecular targets potentially contributing to this state.

194
Q

How is hypnosis measured in clinical settings, and what does it indicate?

A

Hypnosis is typically measured as a loss of response to a command or through the spared arm technique in the presence of neuromuscular blockers. It indicates a state of unconsciousness separate from immobility and amnesia.

195
Q

What is the proposed hierarchical process of clinical anesthesia?

A

Clinical anesthesia may involve diminishing afferent sensory impulses (by drugs like opioids), depressing central activating systems (via benzodiazepines, barbiturates, propofol), and suppressing motor reflexes (by volatile anesthetics and others).

196
Q

What is the significance of volatile anesthetics in general anesthesia?

A

Volatile anesthetics are considered ‘total anesthetics’ because they can independently provide general anesthesia. They are effective in depressing motor reflexes, a key component of general anesthesia.

197
Q

How do inhaled anesthetics inhibit synaptic transmission?

A

Certain inhaled anesthetics inhibit synaptic transmission by presynaptic inhibition of neurotransmitter release. This may involve actions on ion channels regulating neurotransmitter release or directly on the release machinery.

198
Q

How does isoflurane affect presynaptic neurotransmitter release?

A

Isoflurane inhibits presynaptic neurotransmitter release, affecting the machinery required for the release process.

199
Q

How do inhaled anesthetics differ in pharmacologic effects at comparable MAC percentages?

A

Inhaled anesthetics produce different pharmacologic effects even at comparable percentages of MAC, indicating that their dose-response curves are not parallel. This variation is observed in their effects on various organ systems.

200
Q

What is the basis for comparing the pharmacologic effects of inhaled anesthetics?

A

Comparisons are based on measurements from normothermic volunteers under controlled ventilation and normocapnia, exposed to equal potent concentrations of inhaled anesthetics.

201
Q

How might the response to inhaled anesthetics differ between healthy volunteers and surgical patients?

A

Surgically stimulated patients with various confounding variables may respond differently to inhaled anesthetics compared to the responses observed in healthy volunteers.

202
Q

What specific advantages do desflurane and sevoflurane have over other potent inhaled anesthetics?

A

Desflurane and sevoflurane have lower blood and tissue solubility, allowing for more precise control during induction and faster recovery upon discontinuation. Their other properties mostly resemble those of their predecessors.

203
Q

What are the variable that influence Pharmacologic effect of Inhaled Anesthetics?

A
  • Anesthetic concentration
  • Rate of increase in anesthetic concentration
  • Spontaneous versus controlled ventilation
  • Variations from normocapnia
  • Surgical stimulation
  • Patient age
  • Coexisting disease
  • Concomitant drug therapy
  • Intravascular fluid volume
  • Preoperative medication
  • Injected drugs to induce and/or maintain anesthesia or skeletal muscle relaxation
  • Alterations in body temperature
204
Q

Is mental impairment detectable in individuals exposed to trace concentrations of nitrous oxide or halothane?

A

Mental impairment is not detectable in volunteers exposed to 0.16% nitrous oxide or 0.0016% halothane, suggesting that operating room personnel using modern anesthetic scavenging techniques are unlikely to experience mental impairment from trace anesthetic exposure.

205
Q

At what concentration does nitrous oxide begin to significantly affect reaction times?

A

Reaction times do not significantly increase until individuals inhale 10% to 20% nitrous oxide.

206
Q

How do anesthetics affect cerebral metabolic oxygen requirements?

A

Cerebral metabolic oxygen requirements decrease in parallel with reductions in cerebral activity induced by anesthetics.

207
Q

How might anesthetics affect intracranial pressure (ICP)?

A

Drug-induced increases in cerebral blood flow (CBF) can lead to elevated intracranial pressure, particularly in patients with space-occupying lesions.

208
Q

Do desflurane and sevoflurane differ from older inhaled anesthetics in terms of CNS effects?

A

The effects of desflurane and sevoflurane on the CNS do not significantly differ from those of older inhaled anesthetics.

209
Q

How do volatile anesthetics affect the EEG at concentrations of <0.4 MAC?

A

At concentrations below 0.4 MAC, volatile anesthetics increase EEG frequency and voltage, corresponding to the “excitement stage” of anesthesia.

210
Q

What EEG changes occur around 0.4 MAC of volatile anesthetic?

A
  • There is a shift of high-voltage activity from posterior to anterior brain regions
  • cerebral metabolic oxygen requirements decrease,
  • likely indicating a transition from wakefulness to unconsciousness.
211
Q

What happens to the EEG as the dose of volatile anesthetic approaches 1 MAC?

A
  • EEG frequency decreases
  • Voltage increases
  • During isoflurane administration, burst suppression appears at about 1.5 MAC, with electrical silence at 2 MAC.
212
Q

How do the EEG effects of halothane, enflurane, and nitrous oxide differ?

A
  • Electrical silence is not observed with enflurane
  • High concentrations (>3.5 MAC) of halothane are required for this effect.
  • Nitrous oxide produces slower frequency and higher voltage on the EEG, similar to volatile anesthetics.
213
Q

What are the EEG effects of desflurane and sevoflurane?

A

Desflurane and sevoflurane cause dose-related changes in the EEG similar to isoflurane. Desflurane initially increases frequency and lowers voltage at low concentrations, with higher concentrations leading to increased voltage and electrical silence at 1.5 to 2.0 MAC.

214
Q

How does enflurane affect seizure activity?

A

Enflurane can induce EEG changes similar to seizures, especially at concentrations >2 MAC or with significant hyperventilation. It may cause tonic-clonic muscle twitching, but does not generally enhance preexisting seizure foci.

215
Q

Does isoflurane evoke seizure activity?

A

Isoflurane does not induce seizure activity on EEG, even under deep anesthesia or hypocapnia. It possesses anticonvulsant properties and can suppress seizures induced by other agents.

216
Q

Do desflurane and sevoflurane cause convulsive activity on EEG?

A

Desflurane and sevoflurane generally do not produce EEG evidence of convulsive activity, though there are reports of EEG seizure activity during sevoflurane anesthesia in certain individuals.

217
Q

How does nitrous oxide influence seizure activity?

A

Nitrous oxide may increase motor activity and induce seizures, especially at high concentrations in hyperbaric settings. It may also be associated with withdrawal seizures and post-anesthesia delirium or excitement.

218
Q

What is the phenomenon of withdrawal seizures associated with nitrous oxide?

A

Withdrawal seizures can occur in animals after discontinuation of nitrous oxide, possibly reflecting acute dependence. Similar phenomena might occur in humans, manifesting as delirium or excitement during recovery.

219
Q

How do volatile anesthetics affect evoked potentials?

A

Volatile anesthetics cause a dose-related decrease in amplitude and an increase in latency of cortical components of median nerve somatosensory, visual, and auditory evoked potentials, with amplitude decreases being more pronounced than latency increases.

220
Q

What effect does nitrous oxide have on cortical somatosensory evoked potentials?

A

Nitrous oxide, even on its own, can decrease the amplitude of cortical somatosensory evoked potentials. When combined with halothane, enflurane, or isoflurane, it allows for adequate waveform monitoring at specific MAC levels.

221
Q

What are the effects of halothane, enflurane, and isoflurane on evoked potentials in the presence of nitrous oxide?

A

Adequate cortical somatosensory evoked potential waveforms can be monitored with 60% nitrous oxide during administration of 0.50 to 0.75 MAC halothane and 0.5 to 1.0 MAC enflurane and isoflurane.

222
Q

How does desflurane affect somatosensory evoked potentials?

A

Desflurane increasingly depresses somatosensory evoked potentials in patients at peri-MACs ranging from 0.5 to 1.5 MAC.

223
Q

What is the effect of inhaled anesthetics at MAC-awake concentrations?

A

Inhaled anesthetics cause loss of response to verbal command at MAC-awake concentrations, which is typically a lower concentration than that required for full anesthesia.

224
Q

Can lower concentrations of inhaled anesthetics affect mental function?

A

Subtle effects on mental function, such as learning impairment, may occur at anesthetic concentrations as low as 0.2 MAC.

225
Q

How effective are different gaseous anesthetics in preventing awareness?

A

Gaseous anesthetics vary in their effectiveness to prevent awareness. For instance, 0.4 MAC isoflurane prevents recall and responses to commands, while nitrous oxide requires more than 0.5 to 0.6 MAC to achieve similar effects.

226
Q

How does surgical stimulation affect the anesthetic requirement for preventing awareness?

A

Surgical stimulation may increase the anesthetic requirement to prevent awareness, indicating a higher concentration of anesthetic may be needed during active surgical procedures.

227
Q

How do volatile anesthetics affect cerebral blood flow (CBF)?

A

Volatile anesthetics produce dose-dependent increases in CBF, which occurs despite decreases in cerebral metabolism. The magnitude of CBF increase depends on the balance between the drug’s vasodilatory actions and flow-metabolism coupling.

228
Q

How do sevoflurane and isoflurane affect CBF?

A

Sevoflurane has a dose-dependent cerebral vasodilatory effect, less than that of isoflurane. Both desflurane and isoflurane are similar in increasing CBF and maintaining reactivity to carbon dioxide.

229
Q

What is the effect of nitrous oxide on CBF?

A

Nitrous oxide increases CBF, potentially more potently than an equipotent dose of isoflurane. However, its use at concentrations <1 MAC limits the magnitude of this change.

230
Q

How does CBF change over time with halothane administration?

A

In animals, halothane-induced increases in CBF return to baseline levels over time, starting after about 30 minutes and normalizing after about 150 minutes. This normalization is not seen in patients during surgery, where CBF remains increased.

231
Q

How do inhaled anesthetics affect the autoregulation of CBF?

A

Isoflurane retains CBF autoregulation in response to changes in systemic blood pressure at 1 MAC, unlike halothane. Desflurane and sevoflurane do not significantly alter CBF autoregulation, with cerebrovascular carbon dioxide reactivity being largely intact.

232
Q

How do inhaled anesthetics affect cerebral metabolic oxygen requirements?

A

Inhaled anesthetics produce dose-dependent decreases in cerebral metabolic oxygen requirements. Isoflurane leads to a greater decrease than an equivalent MAC of halothane.

233
Q

What happens to cerebral metabolic oxygen requirements when the EEG becomes isoelectric?

A

Once the EEG is isoelectric, increasing the concentration of volatile anesthetics further does not produce additional decreases in cerebral metabolic oxygen requirements.

234
Q

Why might isoflurane not always increase CBF at concentrations lower than 1 MAC?

A

Isoflurane’s greater decrease in cerebral metabolism means less CO2 production, which can oppose increases in CBF. Unexpected increases in CBF might occur if isoflurane is administered to patients whose cerebral metabolism is already decreased by other drugs.

235
Q

How do desflurane and sevoflurane affect cerebral metabolic oxygen requirements?

A

Desflurane and sevoflurane decrease cerebral metabolic oxygen requirements in a manner similar to isoflurane.

236
Q

Do different volatile anesthetics affect neurologic outcomes?

A

Neurologic outcomes are generally not different based on the type of volatile anesthetic used. However, data suggest that isoflurane may offer some degree of cerebral protection compared to enflurane and halothane.

237
Q

How might isoflurane provide cerebral protection during surgeries?

A

Isoflurane may blunt necrotic processes resulting from cerebral ischemia, particularly in procedures like carotid endarterectomy. Additionally, during controlled hypotension for cerebral aneurysm clipping, isoflurane can favorably alter the global cerebral oxygen supply-demand balance.

238
Q

How do inhaled anesthetics affect intracranial pressure (ICP)?

A

Inhaled anesthetics increase ICP, with this increase paralleling the rise in cerebral blood flow (CBF). Patients with intracranial masses are especially susceptible to these ICP increases.

239
Q

What is the effect of desflurane on ICP in patients with intracranial masses?

A

In hypocapnic humans with intracranial masses, desflurane at concentrations <0.8 MAC does not increase ICP, while 1.1 MAC can increase ICP by about 7 mm Hg.

240
Q

How does hyperventilation affect ICP in the context of inhaled anesthetics?

A

Hyperventilation, reducing PaCO2 to about 30 mm Hg, can oppose the tendency of inhaled anesthetics to increase ICP.

241
Q

What are the implications of hyperventilation with enflurane administration?

A

With enflurane, hyperventilation increases the risk of seizure activity, which can lead to increased cerebral metabolism and CO2 production, potentially increasing CBF and ICP.

242
Q

How does nitrous oxide affect ICP compared to volatile anesthetics?

A

The ability of nitrous oxide to increase ICP is probably less than that of volatile anesthetics, partly due to its restricted dose of <1 MAC.

243
Q

How does isoflurane affect CSF production and reabsorption?

A

Isoflurane does not alter the production of CSF but decreases the resistance to its reabsorption. This aligns with the minimal increases in ICP observed during isoflurane administration.

244
Q

Does nitrous oxide enhance CSF production?

A

Increases in ICP associated with nitrous oxide are presumed to be due to increases in CBF. Nitrous oxide does not enhance CSF production.

245
Q

What are the general circulatory effects of inhaled anesthetics?

A

Inhaled anesthetics produce dose-dependent and drug-specific effects on the circulatory system, including changes in blood pressure, heart rate, cardiac output, stroke volume, right atrial pressure, systemic vascular resistance, cardiac rhythm, and coronary blood flow.

246
Q

How do desflurane and sevoflurane compare to older inhaled anesthetics in terms of circulatory effects?

A

Desflurane’s circulatory effects are similar to isoflurane, while sevoflurane shares characteristics with both isoflurane and halothane.

247
Q

What factors can cause variability in the circulatory responses to inhaled anesthetics?

A

Circulatory responses can vary with controlled versus spontaneous breathing, preexisting cardiac disease, and the presence of drugs affecting the heart.

248
Q

What are the mechanisms behind the circulatory effects of inhaled anesthetics?

A

The circulatory effects often reflect inhaled anesthetics’ influence on myocardial contractility, peripheral vascular smooth muscle tone, and autonomic nervous system activity.

249
Q

How do halothane, isoflurane, desflurane, and sevoflurane affect mean arterial pressure?

A

These anesthetics produce similar, dose-dependent decreases in mean arterial pressure in healthy volunteers, with the magnitude of decrease being greater than during surgical stimulation.

250
Q

How might preoperative blood pressure levels influence the blood pressure response to volatile anesthetics?

A

Artificially elevated preoperative blood pressure levels, possibly due to apprehension, may result in greater decreases in blood pressure than the actual pharmacologic effect of the volatile anesthetic.

251
Q

What effect does nitrous oxide have on systemic blood pressure?

A

Nitrous oxide generally causes no change or modest increases in systemic blood pressure. Substituting nitrous oxide for a portion of volatile anesthetic decreases the extent of blood pressure decrease caused by the anesthetic alone.

252
Q

What are the mechanisms behind the blood pressure changes caused by different volatile anesthetics?

A

The blood pressure decrease with halothane is partly due to reductions in myocardial contractility and cardiac output, while with isoflurane, desflurane, and sevoflurane, it primarily results from decreased systemic vascular resistance.

253
Q

How do isoflurane, desflurane, and sevoflurane affect heart rate?

A

Isoflurane and desflurane tend to increase heart rate at lower concentrations, whereas sevoflurane increases heart rate only at concentrations >1.5 MAC. Halothane does not increase heart rate.

254
Q

How might heart rate responses to anesthetics in surgical patients differ from those in volunteers?

A

Heart rate effects in surgical patients can differ significantly from those in volunteers due to confounding variables like surgical stress, preoperative medication, and sympathetic nervous system activity.

255
Q

What is the effect of pre-anesthetic opioids on heart rate response to volatile anesthetics?

A

A small dose of opioid premedication can prevent the heart rate increase commonly associated with isoflurane and possibly other volatile anesthetics.

256
Q

What are the effects of halothane on heart rate?

A

Halothane may lead to an unchanged or decreased heart rate despite a drop in blood pressure, likely due to suppression of the sinus node and carotid sinus baroreceptor reflex response. It can also cause junctional rhythm and slow cardiac impulse conduction.

257
Q

Does age affect heart rate response to isoflurane?

A

Heart rate responses to isoflurane are blunted in elderly patients, while younger patients are more likely to experience increased heart rates, especially in the presence of drugs with vagolytic effects.

258
Q

How does halothane affect cardiac output?

A

Halothane produces dose-dependent decreases in cardiac output in healthy human volunteers. Its effect on cardiac output is more pronounced than other volatile anesthetics.

259
Q

Do isoflurane, desflurane, and sevoflurane decrease cardiac output?

A

Isoflurane, desflurane, and sevoflurane do not significantly decrease cardiac output. Sevoflurane decreases cardiac output only at higher concentrations but recovers near awake values at 2 MAC.

260
Q

How do various volatile anesthetics affect left ventricular stroke volume?

A

Despite differences in heart rate effects, all volatile anesthetics decrease left ventricular stroke volume by 15% to 30%.

261
Q

What effect does nitrous oxide have on cardiac output?

A

Nitrous oxide modestly increases cardiac output, likely due to its mild sympathomimetic effects.

262
Q

How do volatile anesthetics compare in terms of direct myocardial depression?

A

Volatile anesthetics depress myocardial contractility in vitro. However, the vasodilating effects of ether-derivative anesthetics make their myocardial depression less apparent than halothane’s. Nitrous oxide’s myocardial depressant effects are milder and often offset by its sympathomimetic properties.

263
Q

How do halothane, isoflurane, and desflurane affect right atrial pressure?

A

Halothane, isoflurane, and desflurane increase right atrial pressure (central venous pressure) in healthy volunteers, with minimal changes at 1 MAC. Sevoflurane, however, does not significantly affect right atrial pressure.

264
Q

How do the peripheral vasodilating effects of volatile anesthetics impact right atrial pressure?

A

The peripheral vasodilating effects of volatile anesthetics tend to minimize the impact of their direct myocardial depression on right atrial pressure.

265
Q

How does nitrous oxide affect right atrial pressure?

A

Nitrous oxide can increase right atrial pressure, likely due to increased pulmonary vascular resistance from its sympathomimetic effects.

266
Q

How do isoflurane, desflurane, and sevoflurane affect systemic vascular resistance?

A

Isoflurane, desflurane, and sevoflurane decrease systemic vascular resistance, leading to a decrease in blood pressure primarily through vasodilation. Halothane, however, does not change systemic vascular resistance significantly.

267
Q

What mechanism does halothane use to decrease systemic blood pressure?

A

Halothane decreases systemic blood pressure mainly by reducing cardiac output, not by changing systemic vascular resistance.

268
Q

Does nitrous oxide affect systemic vascular resistance?

A

Nitrous oxide does not significantly change systemic vascular resistance.

269
Q

What are the effects of isoflurane on blood flow in different body parts?

A

Isoflurane significantly increases skeletal muscle and cutaneous blood flow, which can lead to excessive perfusion, loss of body heat, and enhanced drug delivery to areas like the neuromuscular junction.

270
Q

How does halothane’s vasodilating effect compare in different organs?

A

While halothane is a potent cerebral and cutaneous vasodilator, its effects are balanced by unchanged or constricted blood flow in other vascular beds, resulting in an overall unchanged systemic vascular resistance.

271
Q

How do volatile anesthetics affect cutaneous blood flow?

A

All volatile anesthetics increase cutaneous blood flow, which can arterialize peripheral venous blood. This effect can provide an alternative means of evaluating pH and PaCO2 without needing arterial blood samples.

272
Q

What is the likely mechanism for the increase in cutaneous blood flow caused by volatile anesthetics?

A

The increase in cutaneous blood flow most likely results from a central inhibitory action of volatile anesthetics on temperature-regulating mechanisms.

273
Q

What effect do volatile anesthetics have on pulmonary vascular resistance?

A

Volatile anesthetics generally have little or no predictable effect on pulmonary vascular smooth muscle, meaning they don’t significantly alter pulmonary vascular resistance

274
Q

How does nitrous oxide affect pulmonary vascular resistance?

A

Nitrous oxide can increase pulmonary vascular resistance, which is especially pronounced in patients with existing pulmonary hypertension or in neonates.

275
Q

What is the concern with using nitrous oxide in patients with congenital heart disease

A

In patients with congenital heart disease, the increase in pulmonary vascular resistance due to nitrous oxide may exacerbate right-to-left intracardiac shunting, worsening arterial oxygenation.

276
Q

How do different volatile anesthetics affect the susceptibility to epinephrine-induced ventricular cardiac dysrhythmias?

A

Halothane, an alkane derivative, greatly increases the sensitivity to epinephrine-induced ventricular dysrhythmias. In contrast, ether derivatives like isoflurane, desflurane, and sevoflurane have minimal to no effect in increasing this susceptibility.

277
Q

Which volatile anesthetics are known to prolong the QTc interval?

A

Halothane, enflurane, and isoflurane can prolong the QTc interval on the electrocardiogram in healthy patients. Sevoflurane has also been reported to prolong the QTc interval, especially in patients with long QTc syndrome.

278
Q

How do anesthetics affect patients with idiopathic long QTc syndrome differently?

A

Generalizations from healthy patients may not be valid for those with idiopathic long QTc syndrome. Sevoflurane, in particular, has been noted to prolong the QT interval in these patients.

279
Q

How does the effect of sevoflurane on the QTc interval compare with propofol?

A

Sevoflurane can prolong the QTc interval in healthy patients, unlike propofol, which does not have this effect.

280
Q

How do anesthetics affect sympathetically driven arrhythmias like supraventricular and ventricular tachycardia?

A

Most anesthetic agents, including volatile anesthetics, tend to suppress these arrhythmias by reducing adrenergic tone. Volatile anesthetics are preferred for minimal interference.

281
Q

What is the effect of propofol on arrhythmias?

A

Propofol can suppress ectopic atrial tachycardia in children and may be used to control electrical storm. It does not generally inhibit other arrhythmias.

282
Q

Does ketamine affect arrhythmias?

A

Ketamine does not inhibit arrhythmias. It does not alter sinoatrial or atrioventricular node function but can stimulate hemodynamics through adrenergic stimulation.

283
Q

How do circulatory effects of volatile anesthetics differ during spontaneous breathing compared to controlled ventilation?

A

During spontaneous breathing, volatile anesthetics lead to increased systemic blood pressure and heart rate, and decreased systemic vascular resistance, due to sympathetic stimulation from CO2 accumulation and improved venous return.

284
Q

What role does CO2 play in circulatory changes during spontaneous breathing under volatile anesthetics?

A

Accumulation of CO2 during spontaneous breathing can stimulate the sympathetic nervous system (respiratory acidosis) and might directly relax peripheral vascular smooth muscle, affecting circulatory dynamics.

285
Q

Compare the circulatory effects of volatile anesthetics under spontaneous breathing vs. controlled ventilation.

A

Under spontaneous breathing, volatile anesthetics increase blood pressure and heart rate, with lower systemic vascular resistance, compared to controlled ventilation which maintains normocapnia.

286
Q

How do volatile anesthetics affect coronary blood flow?

A

They induce coronary vasodilation, acting preferentially on vessels with diameters of 20 to 50 microns.

287
Q

Compare the impact of isoflurane and adenosine on coronary vessels.

A

Isoflurane acts on larger coronary vessels (20-50 microns), while adenosine also affects small precapillary arterioles.

288
Q

What is the significance of coronary steal syndrome in the context of volatile anesthetics like isoflurane?

A

Although volatile anesthetics could theoretically cause coronary steal syndrome by redistributing blood from ischemic to nonischemic areas, this effect is not clinically significant.

289
Q

Are volatile anesthetics cardioprotective?

A

Yes, volatile anesthetics, including isoflurane, are considered cardioprotective despite concerns about coronary steal syndrome.

290
Q

How does desflurane affect neurocirculatory responses?

A

Abrupt increases in desflurane concentration can transiently increase mean arterial pressure and heart rate due to sympathetic nervous system and renin-angiotensin activity stimulation.

291
Q

Compare the neurocirculatory responses to rapid increases in isoflurane and desflurane.

A

Both cause transient increases in blood pressure and heart rate, but desflurane induces significantly greater responses.

292
Q

Do neurocirculatory responses accompany abrupt increases in sevoflurane concentration?

A

No, abrupt increases in the delivered concentration of sevoflurane do not trigger neurocirculatory responses.

293
Q

What medications can blunt cardiovascular responses to rapid increases in desflurane concentration?

A
  • Fentanyl (1.5-4.5 μg/kg IV administered 5 minutes before the abrupt increase in desflurane concentration)
  • Esmolol (0.75 mg/kg IV 1.5 minutes before)
  • Clonidine (4.3 μg/kg orally 90 minutes before)
  • can blunt these responses.
  • Fentanyl is particularly effective due to minimal cardiovascular depressant effects and less postanesthetic sedation.
294
Q

How does alfentanil affect hemodynamic responses to increased desflurane concentration?

A

Alfentanil can blunt hemodynamic responses to an abrupt increase in desflurane concentration, but it does not predictably prevent the increase in plasma norepinephrine concentrations.

295
Q

How does preexisting cardiac disease impact the effects of volatile anesthetics?

A

It may exacerbate myocardial depression, especially in cases with already compromised cardiac muscle contractility.

296
Q

Why might abrupt increases in desflurane concentration be problematic for patients with coronary artery disease?

A

It can evoke neurocirculatory responses that are detrimental in coronary artery disease, potentially exacerbating the condition.

297
Q

How does nitrous oxide affect patients with coronary artery disease?

A

It may cause myocardial depression in these patients, a response not seen in individuals without heart disease.

298
Q

How does valvular heart disease affect the response to anesthetics like isoflurane?

A

Peripheral vasodilation from isoflurane can be harmful in aortic stenosis but beneficial in mitral/aortic regurgitation.

299
Q

How can prior drug therapy influence the effects of volatile anesthetics?

A

Drugs that alter sympathetic nervous activity, like antihypertensives or β-blockers, can modify the circulatory effects of anesthetics.

300
Q

How do calcium entry blockers affect sensitivity to inhaled anesthetics?

A

They decrease myocardial contractility, making the heart more susceptible to the depressant effects of anesthetics.

301
Q

What are the proposed mechanisms for the cardiovascular depressant effects of volatile anesthetics?

A

Mechanisms include direct myocardial depression, inhibition of CNS sympathetic activity, peripheral autonomic ganglion blockade, attenuated carotid sinus reflex activity, decreased cyclic AMP formation, reduced catecholamine release, and decreased calcium ion influx.

302
Q

How does isoflurane differ from other volatile anesthetics in terms of cardiovascular effects?

A

Isoflurane may exhibit mild β-adrenergic agonist properties, contributing to maintained cardiac output, increased heart rate, and decreased systemic vascular resistance.

303
Q

What happens to blood pressure during rapid increases in desflurane concentration?

A

Rapid increases in desflurane lead to a significant blood pressure rise, accompanied by increased plasma epinephrine, suggesting enhanced adrenal gland activity.

304
Q

What are the sympathomimetic effects observed with nitrous oxide administration?

A

Nitrous oxide can cause increased plasma catecholamine levels, mydriasis, body temperature rise, diaphoresis, elevated right atrial pressure, and systemic and pulmonary vasoconstriction.

305
Q

How do opioids affect the circulatory response to nitrous oxide?

A

Opioids can mask nitrous oxide’s sympathomimetic effects, revealing its direct depressant impact on the heart, characterized by lower blood pressure and cardiac output, and higher left ventricular end-diastolic pressure and systemic vascular resistance.

306
Q

Proteins involved in Cardiac protection.

A
307
Q

What is ischemic preconditioning and its significance in cardiac protection?

A

Ischemic preconditioning refers to brief episodes of myocardial ischemia that occur before a longer period of ischemia, offering protection against myocardial dysfunction and necrosis. This phenomenon involves complex interactions between myocardial organelles and various cells including neurons and lymphocytes. It highlights a protective mechanism that can be targeted for cardiac protection and is also observed in other organs like kidneys.

308
Q

What are the primary effects of inhaled anesthetics on ventilation?

A

Inhaled anesthetics affect ventilation in several dose-dependent and drug-specific ways:

  • They alter the pattern of breathing.
  • They modulate the ventilatory response to carbon dioxide.
  • They affect the ventilatory response to arterial hypoxemia.
  • They influence airway resistance.

Additionally, PaO2 (partial pressure of arterial oxygen) typically decreases during the administration of inhaled anesthetics if supplemental oxygen is not provided.

309
Q

How do inhaled anesthetics generally affect breathing frequency?

A

Except for isoflurane at >1 MAC, inhaled anesthetics cause a dose-dependent increase in the frequency of breathing. This is thought to be due to CNS stimulation. Isoflurane increases breathing frequency up to 1 MAC but not beyond. Nitrous oxide significantly increases breathing frequency at >1 MAC.

310
Q

What is the impact of isoflurane and nitrous oxide on breathing frequency?

A

Isoflurane increases breathing frequency similarly to other anesthetics up to 1 MAC, but not beyond. Nitrous oxide, particularly at concentrations >1 MAC, increases breathing frequency more than other anesthetics and may stimulate pulmonary stretch receptors.

311
Q

How do volatile anesthetics influence central respiratory chemoreceptor neurons?

A

Volatile anesthetics likely stimulate central respiratory chemoreceptor neurons through the activation of THIK-1 receptors, responsible for a background potassium current, influencing breathing frequency.

312
Q

What happens to tidal volume during anesthesia?

A

Tidal volume decreases with anesthetic-induced increases in breathing frequency, leading to a rapid and shallow breathing pattern. This decrease in tidal volume results in reduced minute ventilation and increased PaCO2.

313
Q

How does the breathing pattern change during general anesthesia?

A

During general anesthesia, the breathing pattern becomes regular and rhythmic, contrasting the awake pattern of intermittent deep breaths. This change is characterized by rapid, shallow breaths due to the effects of inhaled anesthetics.

314
Q

How do volatile anesthetics generally affect ventilation?

A

Volatile anesthetics cause a dose-dependent depression of ventilation, leading to decreased responsiveness to carbon dioxide and increased PaCO2 levels.

315
Q

What are the specific effects of desflurane and sevoflurane on ventilation?

A

Desflurane and sevoflurane depress ventilation, causing profound decreases that can lead to apnea between 1.5 and 2.0 MAC. They both increase PaCO2 and reduce the ventilatory response to carbon dioxide.

316
Q

How does Chronic Obstructive Pulmonary Disease (COPD) affect ventilatory response to anesthetics?

A

COPD may increase the magnitude of PaCO2 when volatile anesthetics are used, accentuating ventilatory depression.

317
Q

How does nitrous oxide affect ventilation in contrast to other anesthetics?

A

Nitrous oxide does not increase PaCO2. When combined with volatile anesthetics, it results in less depression of ventilation and a smaller increase in PaCO2 compared to volatile anesthetics alone.

318
Q

How do anesthetics affect the carbon dioxide response curve?

A

All inhaled anesthetics, including nitrous oxide, decrease the slope of the carbon dioxide response curve and shift it to the right. Subanesthetic levels (0.1 MAC) do not alter the ventilatory response to carbon dioxide

319
Q

What factors influence the increase in PaCO2 under anesthesia?

A

Painful stimulation (such as surgical skin incision) and the duration of anesthetic administration can significantly affect the increase in PaCO2 produced by volatile anesthetics.

320
Q

How does surgical stimulation impact minute ventilation and PaCO2?

A
  • Increases minute ventilation by approximately 40% due to rises in both tidal volume and frequency of breathing
  • PaCO2 decreases by only about 10% (4-6 mm Hg) despite this increase in minute ventilation.
  • This is thought to be due to heightened carbon dioxide production from sympathetic nervous system activation in response to the pain of surgical stimulation, which offsets the effects of increased minute ventilation.
321
Q

How do volatile anesthetics affect the ventilatory response to carbon dioxide?

A
  • Volatile anesthetics like Desflurane and Sevoflurane lead to a dose-dependent depression of ventilation
  • characterized by reduced ventilatory response to carbon dioxide and increased PaCO2.
  • They can cause significant decreases in ventilation, leading to apnea at concentrations between 1.5 and 2.0 MAC.
  • Nitrous Oxide does not have this effect.
  • Nitrous Oxide combined with a volatile anesthetic is less depressing on ventilation and PaCO2 than the volatile anesthetic alone.
  • This suggests a ventilatory depressant–sparing effect of Nitrous Oxide detectable across all volatile anesthetics.
322
Q

How does the duration of anesthetic administration affect ventilation?

A
  • After approximately 5 hours of administering a volatile anesthetic, the increase in PaCO2 produced by spontaneous breathing is less than that observed during the first hour of administration.
  • Additionally, the slope and position of the carbon dioxide response curve return to normal after about 5 hours of administering volatile anesthetics. - The reason for this apparent recovery from the ventilatory depressant effects of volatile anesthetics over time is not fully understood.
323
Q

What is the impact of surgical stimulation on ventilation during anesthesia?

A
  • Surgical stimulation can cause an approximate 40% increase in minute ventilation due to increases in both tidal volume and frequency of breathing.
  • PaCO2 only decreases by about 10% (4-6 mm Hg) despite the larger increase in minute ventilation.
  • This discrepancy is speculated to be due to the increased carbon dioxide production resulting from the activation of the sympathetic nervous system in response to painful surgical stimulation, which counteracts the effects of increased minute ventilation on PaCO2.
324
Q

How is ventilatory depression caused by volatile anesthetics typically managed?

A
  • Most commonly managed through the initiation of mechanical (controlled) ventilation of the patient’s lungs.
  • The inherent ventilatory depressant properties of these anesthetics actually facilitate the transition to controlled ventilation
  • Making this an effective strategy for managing respiratory depression during anesthesia.
325
Q

What is the effect of inhaled anesthetics, including nitrous oxide, on the ventilatory response to hypoxemia?

A

They profoundly depress this response. At 0.1 MAC, they cause 50%-70% depression, while 1.1 MAC leads to 100% depression.

326
Q

How do inhaled anesthetics affect the ventilatory response to carbon dioxide compared to hypoxemia?

A

They cause less significant depression of the ventilatory response to CO2 than to hypoxemia, especially at 0.1 MAC.

327
Q

What is the impact of inhaled anesthetics on the synergistic effect of hypoxemia and hypercapnia on ventilation?

A

Inhaled anesthetics attenuate this usual synergistic effect, reducing the stimulation of ventilation.

328
Q

Does sevoflurane affect men and women differently in terms of ventilatory response to hypoxemia?

A

No, sevoflurane-induced decreases in hypoxic responses are similar in both men and women.

329
Q

Why is sevoflurane particularly useful during thoracic surgery?

A

Sevoflurane is a potent bronchodilator with low blood-gas solubility, allowing rapid anesthesia depth adjustment, and minimal effects on hypoxic pulmonary vasoconstriction.

330
Q

What are the risk factors for developing bronchospasm during anesthesia?

A

Young age (<10 years), perioperative respiratory infection, endotracheal intubation, and presence of COPD.

331
Q

How do isoflurane and sevoflurane affect bronchial dynamics in COPD patients?

A

Both anesthetics produce bronchodilation in COPD patients, with sevoflurane causing moderate bronchodilation.

332
Q

How does desflurane affect patients who smoke?

A

Desflurane can induce bronchoconstriction, particularly in patients who smoke.

333
Q

How can airway irritability associated with desflurane be decreased?

A

Administering fentanyl or morphine prior to desflurane induction significantly decreases airway irritability.

334
Q

Which is better at suppressing cough responses to tracheal stimulation: sevoflurane or desflurane?

A

Sevoflurane is more effective than desflurane at suppressing moderate to severe cough responses.

335
Q

What is the concern with sevoflurane and desiccated CO2 absorbents?

A

Exposure to these absorbents can produce toxic gases, leading to airway irritation and impaired gas exchange, notably from formaldehyde generation.

336
Q

What is the historical perspective on inhalational anesthetics as neuroprotective agents?

A
  • Originated in the 1960s.
  • Initially thought to increase tolerance to cerebral ischemia.
  • Positive associations in early studies, but not confirmed in high-quality, prospective studies.
337
Q

What is the concept of ischemic preconditioning related to anesthetics?

A
  • Suggests brief ischemia episodes can protect against longer ischemic periods.
  • Demonstrated in other organs like kidneys.
  • Brought forth by early anesthetic studies.
338
Q

What are the concerns regarding neurotoxicity and inhalational anesthetics?

A
  • Supported by animal studies, especially at extreme ages.
  • Associated with neuronal, glial apoptosis, and calcium dysregulation.
  • Potential postoperative cognitive effects in the elderly.
339
Q

How does anesthesia potentially affect elderly patients neurologically?

A
  • May lead to postoperative delirium.
  • Postoperative cognitive dysfunction in 20%-40% of patients over 60.
340
Q

What are the findings regarding anesthesia’s neurotoxicity in children?

A
  • Early exposure linked to neurodegeneration and learning deficits in animal studies.
  • Concerns over prolonged exposure from observational studies.
  • FDA warning on anesthesia and brain development
341
Q

What is the SmartTots initiative’s focus on pediatric anesthesia?

A
  • Studies the impact of anesthetic exposure on young children’s brain development.
  • Concerns over multiple, prolonged anesthesia exposures.
342
Q

How does isoflurane affect hepatic blood flow?

A
  • Isoflurane maintains total hepatic and hepatic artery blood flow.
  • Increases portal vein blood flow.
  • Acts as a vasodilator, enhancing hepatic oxygen delivery.
343
Q

What are the differences between halothane and isoflurane in terms of hepatic circulation?

A
  • Halothane acts as a vasoconstrictor.
  • Isoflurane increases hepatic blood flow and venous oxygen saturation.
  • Halothane does not change hepatic blood flow under similar conditions.
344
Q

How do desflurane and sevoflurane impact hepatic blood flow?

A
  • Both maintain hepatic blood flow similar to isoflurane.
  • Contributes to maintaining hepatic oxygen delivery.
345
Q

Why is maintaining hepatic oxygen delivery during anesthesia important?

A
  • Crucial for preventing postoperative hepatic dysfunction.
  • Hepatocyte hypoxia is a key factor in hepatic dysfunction etiology.
346
Q

How do volatile anesthetics impact drug clearance?

A
  • They can decrease the intrinsic hepatic metabolism of certain drugs (e.g., propranolol) by 54-68%.
  • This is mainly due to anesthetic-induced inhibition of hepatic drug-metabolizing enzymes.
347
Q

How do volatile anesthetics like desflurane and isoflurane affect liver function tests?

A
  • Desflurane can cause transient increases in plasma alanine aminotransferase activity.
  • Both isoflurane and desflurane may lead to temporary rises in α-glutathione transferase, indicating hepatocellular injury.
  • Surgical stimulation, regardless of the anesthetic, can transiently impact hepatic function, evident in changes like bromsulphalein retention and liver enzyme elevation.
348
Q

What is the relationship between volatile anesthetics and postoperative liver dysfunction?

A
  • Halothane is most notably associated with postoperative liver dysfunction, often linked to its metabolism and subsequent free radical production.
  • These free radicals can alter hepatic proteins, potentially creating antigens that trigger immune responses.
  • Preexisting liver conditions like hepatic cirrhosis are at higher risk, as anesthetics can further reduce hepatic oxygenation.
  • Hypothermia during surgery may protect the liver by reducing hepatic oxygen demand and mitigating the impact of anesthetics.
349
Q

What are the two types of hepatotoxicity associated with Halothane?

A
  • Mild, self-limited postoperative hepatotoxicity: Occurs in ~20% of adults, marked by nausea, lethargy, fever, and minor liver enzyme increases. Likely related to hepatic blood flow changes impairing oxygenation.
  • Halothane hepatitis: Rarer, severe form, affecting 1 in 10,000 to 30,000 adults. Can lead to massive hepatic necrosis and death. Believed to be immune-mediated. Children are less susceptible.
350
Q

What are the clinical manifestations and risk factors for Halothane Hepatitis?

A
  • Manifestations: Eosinophilia, fever, rash, arthralgia, previous halothane exposure.
  • Risk Factors: Female gender, middle age, obesity, multiple halothane exposures.
  • Mechanism: Immune-mediated; antibodies against liver proteins modified by halothane metabolites.
    Histology: Acute hepatitis; genetic susceptibility suggested.